Pharmacology of adenosine receptors: the state of the art
Adenosine is a ubiquitous endogenous autacoid whose effects are triggered through the
enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Due to the rapid …
enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Due to the rapid …
[HTML][HTML] Dopamine in health and disease: much more than a neurotransmitter
Dopamine is derived from an amino acid, phenylalanine, which must be obtained through
the diet. Dopamine, known primarily to be a neurotransmitter involved in almost any higher …
the diet. Dopamine, known primarily to be a neurotransmitter involved in almost any higher …
Caffeine use in children: what we know, what we have left to learn, and why we should worry
JL Temple - Neuroscience & Biobehavioral Reviews, 2009 - Elsevier
Caffeine is a widely used psychoactive substance in both adults and children that is legal,
easy to obtain, and socially acceptable to consume. Although once relatively restricted to …
easy to obtain, and socially acceptable to consume. Although once relatively restricted to …
[HTML][HTML] Genetics of caffeine consumption and responses to caffeine
Rationale Caffeine is widely consumed in foods and beverages and is also used for a
variety of medical purposes. Despite its widespread use, relatively little is understood …
variety of medical purposes. Despite its widespread use, relatively little is understood …
[HTML][HTML] Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa
Y Smith, T Wichmann, SA Factor… - …, 2012 - nature.com
The demonstration that dopamine loss is the key pathological feature of Parkinson's disease
(PD), and the subsequent introduction of levodopa have revolutionalized the field of PD …
(PD), and the subsequent introduction of levodopa have revolutionalized the field of PD …
Targeting adenosine A2A receptors in Parkinson's disease
MA Schwarzschild, L Agnati, K Fuxe, JF Chen… - Trends in …, 2006 - cell.com
The adenosine A 2A receptor has emerged as an attractive non-dopaminergic target in the
pursuit of improved therapy for Parkinson's disease (PD), based in part on its unique CNS …
pursuit of improved therapy for Parkinson's disease (PD), based in part on its unique CNS …
[HTML][HTML] Dopamine, behavioral economics, and effort
JD Salamone, M Correa, AM Farrar… - Frontiers in behavioral …, 2009 - frontiersin.org
There are numerous problems with the hypothesis that brain dopamine (DA) systems,
particularly in the nucleus accumbens, directly mediate the rewarding or primary …
particularly in the nucleus accumbens, directly mediate the rewarding or primary …
Glutamate receptors as therapeutic targets for Parkinson's disease
KA Johnson, PJ Conn… - CNS & Neurological …, 2009 - ingentaconnect.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms
including tremor and bradykinesia. The primary pathophysiology underlying PD is the …
including tremor and bradykinesia. The primary pathophysiology underlying PD is the …
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher‐order oligomers in living cells
N Cabello, J Gandía, DCG Bertarelli… - Journal of …, 2009 - Wiley Online Library
G protein‐coupled receptors are known to form homo‐and heteromers at the plasma
membrane, but the stoichiometry of these receptor oligomers are relatively unknown. Here …
membrane, but the stoichiometry of these receptor oligomers are relatively unknown. Here …
Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis
Traumatic brain injury (TBI) represents a significant cause of death and disability in
industrialized countries. Of particular importance to patients the chronic effect that TBI has on …
industrialized countries. Of particular importance to patients the chronic effect that TBI has on …